These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22167537)

  • 1. Prostaglandin-timolol fixed combinations efficacy: myth or reality?
    Konstas AG; Haidich AB; Rossetti L; Webers C
    Eur J Ophthalmol; 2012; 22(1):1-4. PubMed ID: 22167537
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the fixed combination of bimatoprost/timolol really produce a better benefit/risk balance than the fixed combination of latanoprost/timolol?
    Soto J; Diaz S
    Eur J Ophthalmol; 2010; 20(1):246-7; author reply 247-8. PubMed ID: 20047180
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.
    Aptel F; Cucherat M; Denis P
    Eur J Ophthalmol; 2012; 22(1):5-18. PubMed ID: 22167538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
    Nixon DR
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients.
    Martinez A; Sanchez M
    Eye (Lond); 2009 Apr; 23(4):810-8. PubMed ID: 18535605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
    Li N; Chen XM; Zhou Y; Wei ML; Yao X
    Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bimatoprost therapy in glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):34-45. PubMed ID: 19899545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.
    Hommer A; Wickstrøm J; Friis MM; Steeds C; Thygesen J; Ferreras A; Gouws P; Buchholz P
    Curr Med Res Opin; 2008 Apr; 24(4):1057-63. PubMed ID: 18315942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on Efficacy and tolerability of prostaglandin analogs.
    Eisenberg D
    J Glaucoma; 2009 Aug; 18(6):498; author reply 498-9. PubMed ID: 19593206
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fixed combination of topical prostaglandin analogue in glaucoma treatment].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(3):82-8. PubMed ID: 22428296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prostaglandin wars.
    Kaufman PL
    Am J Ophthalmol; 2003 Oct; 136(4):727-8. PubMed ID: 14516814
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
    Ulaş F; Balbaba M; Çelebi S
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):658-62. PubMed ID: 23461283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma.
    Konstas AG; Mikropoulos DG; Embeslidis TA; Dimopoulos AT; Papanastasiou A; Haidich AB; Stewart WC
    Eye (Lond); 2010 Oct; 24(10):1606-13. PubMed ID: 20651749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The latest developments in glaucoma therapy using fixed combination products].
    Călugăru M; Călugăru D
    Oftalmologia; 2011; 55(3):53-69. PubMed ID: 22428293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study.
    Bernstein P
    Am J Ophthalmol; 2004 Feb; 137(2):387-8; author reply 388-9. PubMed ID: 14962451
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
    Paranhos A; Mendonça M; Silva MJ; Giampani J; Torres RJ; Della Paolera M; Russ H; Lottenberg CL
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):611-5. PubMed ID: 21029020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from timolol.
    Mesci C; Aydin N; Erbil HH
    J Glaucoma; 2011 Oct; 20(8):477-81. PubMed ID: 21048508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monotherapy with lipid structural derivatives in glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2010; 54(2):30-43. PubMed ID: 20827909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.